SCHEMBL23934151

SCHEMBL23934151

COC(C)Oc1cccc(C(=O)Nc2ncc(S(C)(=O)=O)s2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.50
RAB9A P51151 8/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
ALDH1A1 P00352 2/20 0.50
G6PD P11413 1/20 0.50
KMT2A Q03164 6/20 0.49
MEN1 O00255 5/20 0.49
SCD O00767 2/20 0.46
CCNE1 P24864 1/20 0.46
CDK2 P24941 1/20 0.46
CDK5 Q00535 1/20 0.46
GCK P35557 2/20 0.45
KDR P35968 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
DHODH Q02127 1/20 0.45
TP53 P04637 1/20 0.45
CSNK2A2 P19784 1/20 0.45
CSNK2A1 P68400 1/20 0.45
HPGD P15428 2/20 0.44
RXFP1 Q9HBX9 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4755961 0.87 NPC1 (0.48) NPC1RAB9ASMN1; SMN2ALDH1A1G6PD
SCHEMBL703471 0.86 MEN1 (0.51) NPC1RAB9ASMN1; SMN2ALDH1A1G6PD
SCHEMBL703165 0.82 HSD17B1 (0.51) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL4756952 0.82 RAB9A (0.57) NPC1RAB9ASMN1; SMN2G6PDKMT2A
SCHEMBL4757983 0.80 KDR (0.61) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL4756132 0.76 CCNE1 (0.63) NPC1RAB9ASMN1; SMN2ALDH1A1G6PD
SCHEMBL5836282 0.75 CCNE1 (0.69) NPC1RAB9ASMN1; SMN2ALDH1A1G6PD
SCHEMBL4755967 0.75 CSNK2A2 (0.47) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL4756236 0.74 RAB9A (0.44) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL10114373 0.74 GCK (0.40) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3895706-A1 THIAZOLINIDE COMPOUNDS FOR TREATING NON-INFLUENZA VIRAL INFECTIONS Romark Laboratories, L.C. (US) 2021-10-20 EP disclosed